Literature DB >> 8618925

Steroid receptor heterodimerization demonstrated in vitro and in vivo.

W Liu1, J Wang, N K Sauter, D Pearce.   

Abstract

The mineralocorticoid and glucocorticoid receptors (MR and GR, respectively) are members of the intracellular receptor superfamily that bind as homodimers to the same hormone response elements (HREs). Physiological evidence suggests that MR and GR interact with each other in cells that express both receptors, implying that they might directly interact in the regulation of transcription initiation. Indeed, we have found that coexpressed MR and GR interact functionally at the transcriptional level and furthermore that they interact physically through heterodimer formation at a shared HRE in vitro and in vivo. We suggest from these findings that heterodimerization may play an important role in steroid receptor transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618925      PMCID: PMC40381          DOI: 10.1073/pnas.92.26.12480

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Differential regulation of mouse mammary tumor virus-bacterial chloramphenicol acetyltransferase chimeric gene by human mineralocorticoid hormone-receptor complexes.

Authors:  M V Govindan; S Leclerc; R Roy; P Rathanaswami; B X Xie
Journal:  J Steroid Biochem Mol Biol       Date:  1991-07       Impact factor: 4.292

2.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.

Authors:  B F Luisi; W X Xu; Z Otwinowski; L P Freedman; K R Yamamoto; P B Sigler
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

3.  Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor.

Authors:  R Rupprecht; J L Arriza; D Spengler; J M Reul; R M Evans; F Holsboer; K Damm
Journal:  Mol Endocrinol       Date:  1993-04

Review 4.  Retinoid receptors.

Authors:  D J Mangelsdorf; S A Kliewer; A Kakizuka; K Umesono; R M Evans
Journal:  Recent Prog Horm Res       Date:  1993

5.  Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design.

Authors:  C R Vinson; T Hai; S M Boyd
Journal:  Genes Dev       Date:  1993-06       Impact factor: 11.361

6.  Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers.

Authors:  R Kurokawa; V C Yu; A Näär; S Kyakumoto; Z Han; S Silverman; M G Rosenfeld; C K Glass
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

7.  Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element.

Authors:  D Pearce; K R Yamamoto
Journal:  Science       Date:  1993-02-19       Impact factor: 47.728

8.  Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors.

Authors:  A J Adler; M Danielsen; D M Robins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression.

Authors:  D T Chalmers; S P Kwak; A Mansour; H Akil; S J Watson
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

10.  Oncogenic activity of the c-Myc protein requires dimerization with Max.

Authors:  B Amati; M W Brooks; N Levy; T D Littlewood; G I Evan; H Land
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  44 in total

1.  Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest.

Authors:  M P Sherman; C M de Noronha; D Pearce; W C Greene
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Role of central mineralocorticoid receptors in cardiovascular disease.

Authors:  C E Gomez-Sanchez; E P Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors.

Authors:  A Martinho; I Gonçalves; M Costa; C R Santos
Journal:  J Mol Neurosci       Date:  2012-02-28       Impact factor: 3.444

4.  Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.

Authors:  Xi Zhang; Qiaoling Zhou; Lihe Chen; Stefan Berger; Hongyu Wu; Zhou Xiao; David Pearce; Xiaodong Zhou; Wenzheng Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-11

5.  Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor.

Authors:  Tomoshige Kino; Howard Jaffe; Niranjana D Amin; Mayukh Chakrabarti; Ya-Li Zheng; George P Chrousos; Harish C Pant
Journal:  Mol Endocrinol       Date:  2010-03-31

Review 6.  Corticosteroids in the brain. Cellular and molecular actions.

Authors:  M Joëls; E Vreugdenhil
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 7.  Regulation of αENaC transcription.

Authors:  Lihe Chen; Xi Zhang; Wenzheng Zhang
Journal:  Vitam Horm       Date:  2015-02-14       Impact factor: 3.421

8.  Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces.

Authors:  J G Savory; G G Préfontaine; C Lamprecht; M Liao; R F Walther; Y A Lefebvre; R J Haché
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

9.  Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN.

Authors:  Lance A Stechschulte; Leah Wuescher; Joseph S Marino; Jennifer W Hill; Charis Eng; Terry D Hinds
Journal:  J Biol Chem       Date:  2014-05-09       Impact factor: 5.157

10.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.